News, Analysis & Insights on Nutrition, Supplements, and Health
A new study into the ability of mistletoe to decrease the reoccurrence of tumors in bladder cancer patients seems to show that it is as effective as the most common conventional approach, but without the side effects. But scientific opinion is divided...
Chrysantis is ready to start selling EZ Eyes to dietary supplement makers following the FDA's acceptance of the marigold-derived natural zeaxanthin as a new dietary ingredient (NDI), reports Jess Halliday.
A mixture of peptides derived from colostrum could help slow the progression of Alzheimer's disease by reducing the build-up of beta amyloid, a toxic protein that accumulates in the brains of Alzheimer's sufferers, reports Dominique Patton.
US scientists will investigate whether ginger can help cancer patients avoid nausea and vomiting from chemotherapy.
A new invert syrup from British Sugar offers convenience and flexibility benefits for plant bakers.Invasweet was developed to meet the bakery...
UK scientists have identified previously unknown compounds in the potato that are also found in a herbal used to lower blood pressure, reports Dominique Patton.
Pharming has licensed rights to its protein production technology, based on the use of transgenic animals, to AgResearch, the largest government owned research organisation in New Zealand, reports Phil Taylor.
The latest LOHAS consumer trends study suggests that a healthy spin may no longer be enough to lure people to new food and beverage products. Marketers may need to take another look at strategies for capturing the attention of this important group,...
Sabinsa Corporation has lowered the heavy metal limits for Selenium SeLECT in the face of tightening regulations in the European Union and interest from research institutes who wish to use it in studies, reports Jess Halliday.
German plant extracts group Martin Bauer has invested more than €1 million in new technology for its research centre PhytoLab and built a new 1600 square metre laboratory building as part of the expansion, writes Dominique Patton.